Key Insights

Highlights

Treatment Research

1 treatments under study, led by Ibuprofen

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 1 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed with results

Key Signals

Data Visualizations

Phase Distribution

1Total
Phase 1/2 (1)

Trial Status

Unknown1

Clinical Trials (1)

Showing 1 of 1 trials
NCT01149564Phase 1/2Unknown

Comparison of Oral and Intravenous Ibuprofen for PDA Treatment in Premature Infants

Showing all 1 trials

Research Network

Common Treatments

  • Ibuprofen1

Active Sponsors

  • China Medical University Hospital1

Top Investigators

Related Conditions

  • Oral Ibuprofen1
  • Extremely Premature Infants1
  • Pda1

Activity Timeline